Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 29, 2017 09:43 ET | Source: OncBioMune, L.L.C.

OncBioMune CMO Producing First Batch of Tretinoin for Acute Promyelocytic Leukemia

BATON ROUGE, La., Sept. 29, 2017 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the...
September 14, 2017 08:30 ET | Source: Oncbiomune, L.L.C.

OncBioMune Meets Primary Objective in Trial of ProscaVax Immunotherapy Vaccine for Prostate Cancer

BATON ROUGE, La., Sept. 14, 2017 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the...
August 31, 2017 08:38 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Awaits Approval from Regulatory Committee to Commence Phase 2 Trial of ProscaVax as Front Line Prostate Cancer Treatment

BATON ROUGE, LA--(Marketwired - August 31, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development...
August 29, 2017 09:56 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune to Present Abstract on Clinical Trial of Novel Prostate Cancer Vaccine at American Association of Cancer Research Special Conference

BATON ROUGE, LA--(Marketwired - August 29, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development...
August 24, 2017 08:32 ET | Source: OncBioMune Pharmaceuticals, Inc.

Final Patient Completes Treatment in OncBioMune Clinical Trial of ProscaVax for Prostate Cancer

BATON ROUGE, LA--(Marketwired - August 24, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development...
August 22, 2017 08:45 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Submits Documents Necessary to Commercialize Norepinefrine for Low Blood Pressure and Heart Failure in Mexico

BATON ROUGE, LA--(Marketwired - August 22, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development...
August 10, 2017 08:51 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune To Become Exclusive Distributor of Lipomed Drugs in Mexico

BATON ROUGE, LA--(Marketwired - August 10, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development...
August 03, 2017 09:12 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Submits Application to Commercialize Anti-Rabies Drug in Mexico

BATON ROUGE, LA--(Marketwired - August 03, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development...
July 20, 2017 08:30 ET | Source: OncBioMune Pharmaceuticals, Inc.

OncBioMune Acquires Propolis Product Line for German Partner

BATON ROUGE, LA--(Marketwired - July 20, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development...
July 13, 2017 08:30 ET | Source: OncBioMune Pharmaceuticals, Inc.

Phase 2 Trial of ProscaVax for Early-Stage Prostate Cancer Nears Commencement

BATON ROUGE, LA--(Marketwired - July 13, 2017) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a revenue-stage biopharmaceutical company engaged in the development of...